Delivery Order SPE2DR25D3301-SPE2DR26F20FB
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,059.07 delivery order for Varivax vaccine with diluents on December 3, 2025, with an ultimate completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The vaccine delivery will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Varivax vaccine with diluents, valued at $4,997.30 with a firm fixed price structure. The contract is non-competitive and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on January 2, 2026, with a ceiling value of $1,111.33 and an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Varivax vaccine with diluents, valued at $67,346.40 with a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by January 27, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VARIVAX vaccine with diluents on August 12, 2025, with a ceiling value of $1,032.11 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Varivax vaccine with diluents, valued at $1,019.65 with a completion date of December 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents under a firm fixed-price contract valued at $1,122.49. The award, issued on January 5, 2026, with an ultimate completion date of January 27, 2026, represents a non-competitive, direct procurement leveraging the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,001.70 for Varivax vaccine with diluents, with an ultimate completion date of January 23, 2026. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Varivax vaccine with diluents, valued at $3,127.68. This firm fixed price delivery order, with an ultimate completion date of November 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents under a firm fixed price contract valued at $1,053.01. This non-competitive delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20FBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Varivax vaccine with diluents, valued at $33,005.10 with a firm fixed price structure. The contract, which is not set-aside, carries an ultimate completion date of January 27, 2026, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its pharmaceutical distribution and healthcare solutions operations. This delivery order exemplifies AmerisourceBergen's role as a critical vaccine and pharmaceutical supplier within the federal medical supply chain. As a major healthcare distributor, the company holds an expansive $999,999,999.00 IDC with DLA Troop Support Medical (SPE2DX contract) that extends through December 2026, enabling the supply of vaccines, medications, medical devices, and related commodities to support military healthcare programs globally. The Varivax vaccine delivery order fulfills immunization requirements within the Defense Health Agency and broader federal military healthcare system, leveraging AmerisourceBergen's extensive pharmaceutical portfolio and competitive procurement capabilities to ensure vaccine availability for service members and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.0k | 1/4/26 |